Home ⟩ Insights

Insights

Cannabis News

3 min read • February 28, 2024

Curaleaf Price Target Spikes, Fueled By German Cannabis Legalization Changes — ROTH MKM Explains

1 min read • February 9, 2024

Canaccord Genuity Upgrades Aurora Cannabis to Buy, Announces C$0.8 Price Target

1 min read • August 16, 2022

Raymond James Upgrades Auxly Cannabis Group to Outperform, Raises Price Target to C$0.15

5 min read • August 10, 2022

Why Does This Undervalued Cannabis Stock Have An Encouraging Outlook?

2 min read • June 24, 2022

Read Why Cantor Upgraded Aurora Cannabis Stock

1 min read • June 24, 2022

Cantor Fitzgerald Upgrades Aurora Cannabis to Overweight, Raises Price Target to C$4.05

1 min read • May 14, 2021

BMO Capital Upgrades Aurora Cannabis to Market Perform, Lowers Price Target to C$8

1 min read • September 21, 2020

Jefferies Upgrades Aurora Cannabis to Hold

2 min read • July 22, 2020

Why This Hexo Analyst Is Dropping Their Bearish Stance On The Consumer Cannabis Company

1 min read • June 24, 2020

Stifel Upgrades Aurora Cannabis to Hold, Raises Price Target to C$17.5

3 min read • May 15, 2020

Aurora Cannabis Shares Soar On Sales Beat: ‘A Case Of The Patient Being Presumed Dead, When Indeed It’s Not’

1 min read • May 15, 2020

Piper Sandler Upgrades Aurora Cannabis to Neutral, Lowers Price Target of $10

Latest Headlines

4 min read • August 14, 2026

Latest Cannabis Earnings Reports Show Signs Of Recovery Amid Persistent Headwinds

2 min read • August 14, 2026

From Revenue To Cash Flow: Here’s What Auxly’s Q2 Results Reveal

3 min read • August 13, 2026

Ascend Wellness, MariMed Report Higher Q2 Revenue As Retail Cannabis Sales Drive Growth

13 min read • August 13, 2026

Exclusive: Colorado Cannabis Operators Reveal What It Takes to Survive a Mature Market After the Boom

21 min read • August 12, 2026

Boris Jordan Makes the Case for Aurora — and Predicts a Cannabis M&A Wave in 2027

2 min read • August 12, 2026

GrowGeneration Q2 Sales Rise 5.5% YoY As Adjusted EBITDA Turns Positive

5 min read • August 12, 2026

Aurora Challenges Curaleaf’s Account of $4 Takeover Bid, Forms Special Committee

5 min read • August 12, 2026

The Hemp Ban Delay Solves Nothing for Operators. It Just Moves the Planning Problem to December.

2 min read • August 11, 2026

Organigram Q3 Revenue Soars 49% YoY; New Cannabis Acquisition Powers Global Growth Strategy

4 min read • August 11, 2026

BREAKING: Curaleaf Moves to Take Over Aurora Cannabis With $4-Per-Share Proposal

3 min read • August 11, 2026

Senate Vote Delays Federal Hemp THC Ban, Setting Up New Fight in the House

5 min read • August 11, 2026

Vireo Q2 Earnings: Revenue Jumps 335% Following M&A Push, but Margins Tell Another Story

Browse By Channels

After-Hours Center

Analyst Ratings

Be Your Own Boss

Broad U.S. Equity ETFs

california cannabis

cannabis cultivation

cannabis earnings

Christopher Dillis

Congress cannabis

Earnings Misses

Emerging Market ETFs

Emerging Markets

Entrepreneurship

Federal Reserve

Financial Advisors

first quarter earnings

germany cannabis

hemp legalization

hemp regulation

IgniteIt Events

illegal cannabis farms

intoxicating hemp-derived products

Intraday Update

Macro Economic Events

Macro Notification

Market-Moving Exclusives

Movers & Shakers

Personal Finance

Pre-Market Outlook

Small Cap Analysis

Success Stories

UC Berkeley Cannabis Research Center

unlicensed cannabis

Join the Cannabis Revolution

Ready to access the most aggressive cannabis intelligence platform? Get started with IGNITE IT today.